Cargando…
Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019
Autores principales: | O’Brien, Thomas R, Thomas, David L, Jackson, Sarah S, Prokunina-Olsson, Ludmila, Donnelly, Raymond P, Hartmann, Rune |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184357/ https://www.ncbi.nlm.nih.gov/pubmed/32301957 http://dx.doi.org/10.1093/cid/ciaa453 |
Ejemplares similares
-
Genetics of the Human Interferon Lambda Region
por: Prokunina-Olsson, Ludmila
Publicado: (2019) -
Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses
por: Hamming, Ole J, et al.
Publicado: (2013) -
What makes the hepatitis C virus evolve?
por: O'Brien, Thomas R, et al.
Publicado: (2019) -
Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus via interferon-λ in vitro and in mice
por: Sauerhering, Lucie, et al.
Publicado: (2020) -
Interferon-λ and interleukin-22 cooperate for the induction of interferon-stimulated genes and control of rotavirus infection
por: Hernández, Pedro P., et al.
Publicado: (2015)